Immediate Impact

3 by Nobel laureates 7 from Science/Nature 53 hit
Sub-graph 1 of 24

Citing Papers

Bispecific T cell engager therapy for refractory rheumatoid arthritis
2024 Hit
T-cell-engaging bispecific antibodies in cancer
2023 Hit
2 intermediate papers

Works of Michael Stanglmaier being referenced

Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
2013
Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven,
2013

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Stanglmaier 194 177 149 118 117 9 418
Justus Duyster 140 0.7× 101 0.6× 147 1.0× 72 0.6× 144 1.2× 11 489
Pieter Fokko van Loo 208 1.1× 71 0.4× 102 0.7× 108 0.9× 158 1.4× 11 422
Euy Kyun Shin 210 1.1× 185 1.0× 63 0.4× 102 0.9× 169 1.4× 7 424
Julia Halper 240 1.2× 101 0.6× 53 0.4× 117 1.0× 110 0.9× 12 391
S Kiesel 198 1.0× 92 0.5× 125 0.8× 89 0.8× 79 0.7× 13 435
G.G. D’Ancona 151 0.8× 164 0.9× 58 0.4× 107 0.9× 206 1.8× 10 441
GF Hollis 150 0.8× 110 0.6× 87 0.6× 88 0.7× 228 1.9× 8 453
MW Fanger 157 0.8× 118 0.7× 71 0.5× 58 0.5× 146 1.2× 12 417
JR Kalden 224 1.2× 119 0.7× 71 0.5× 42 0.4× 83 0.7× 15 407
Diane Amox 142 0.7× 171 1.0× 88 0.6× 33 0.3× 121 1.0× 9 414

All Works

Loading papers...

Rankless by CCL
2026